These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22827361)

  • 1. Agency perspectives on food safety for the products of animal biotechnology.
    Howard HJ; Jones KM; Rudenko L
    Reprod Domest Anim; 2012 Aug; 47 Suppl 4():127-33. PubMed ID: 22827361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The US FDA and animal cloning: risk and regulatory approach.
    Rudenko L; Matheson JC
    Theriogenology; 2007 Jan; 67(1):198-206. PubMed ID: 17055042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloned animal products in the human food chain: FDA should protect American consumers.
    Butler JE
    Food Drug Law J; 2009; 64(3):473-501. PubMed ID: 19999640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulating (for the benefit of) future persons: a different perspective on the FDA's jurisdiction to regulate human reproductive cloning.
    Javitt GH; Hudson K
    Utah Law Rev; 2003; 2003(4):1201-29. PubMed ID: 15622618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA'S food ingredient approval process: Safety assurance based on scientific assessment.
    Rulis AM; Levitt JA
    Regul Toxicol Pharmacol; 2009 Feb; 53(1):20-31. PubMed ID: 18983884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food from cloned animals is part of our brave old world.
    Miller HI
    Trends Biotechnol; 2007 May; 25(5):201-3. PubMed ID: 17374411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of animal biotechnology: research needs.
    Rexroad CE; Green RD; Wall RJ
    Theriogenology; 2007 Sep; 68 Suppl 1():S3-8. PubMed ID: 17574657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal cloning and the FDA--the risk assessment paradigm under public scrutiny.
    Rudenko L; Matheson JC; Sundlof SF
    Nat Biotechnol; 2007 Jan; 25(1):39-43. PubMed ID: 17211392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA's cloning report bypasses ethics, exposes European dilemma.
    Vermij P
    Nat Biotechnol; 2007 Jan; 25(1):7-8. PubMed ID: 17211377
    [No Abstract]   [Full Text] [Related]  

  • 14. A brave new beef: The US Food and Drug Administration's review of the safety of cloned animal products.
    Solomon LM; Noll RC; Mordkoff DS; Murphy P; Rolerson M
    Gend Med; 2009 Sep; 6(3):402-9. PubMed ID: 19850236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The FDA and drug safety: a proposal for sweeping changes.
    Furberg CD; Levin AA; Gross PA; Shapiro RS; Strom BL
    Arch Intern Med; 2006 Oct; 166(18):1938-42. PubMed ID: 17030825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finding, evaluating, and managing drug-related risks: approaches taken by the US Food and Drug Administration (FDA).
    Weaver J; Grenade LL; Kwon H; Avigan M
    Dermatol Ther; 2009; 22(3):204-15. PubMed ID: 19453344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA reaches final conclusion that food from clones is safe.
    J Am Vet Med Assoc; 2008 Mar; 232(5):667. PubMed ID: 18380061
    [No Abstract]   [Full Text] [Related]  

  • 19. Meet your meat: The argument for increasing education and public outreach regarding the regulation and safety of animal biotechnology.
    Ball KM
    Food Drug Law J; 2013; 68(3):281-307, ii. PubMed ID: 24640611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA's health claim review: whey-protein partially hydrolyzed infant formula and atopic dermatitis.
    Chung CS; Yamini S; Trumbo PR
    Pediatrics; 2012 Aug; 130(2):e408-14. PubMed ID: 22778306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.